Frontiers in Oncology | Cancer Immunity and Immunotherapy

Systematic Review

Accepted on 24 Jun 2025

Systematic literature review of real-world evidence on overall survival in cancer patients before and after the approval of anti-PD-(L)1 therapy

in Cancer Immunity and Immunotherapy

Dweeti Nayak
Katherine Akers
Andrew Frederickson
Yves P.V. Mbous
Raquel Aguiar-Ibanez

Frontiers in Oncology

doi 10.3389/fonc.2025.1615795

Opinion

Accepted on 24 Jun 2025

Oncolytic Virus VG161 Offers New Hope for Refractory Liver Cancer

in Cancer Immunity and Immunotherapy

Jinqiu Li
Haiyan Zhou
Xinping Wang
Kai Huang
Yanjun Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1605177

Original Research

Published on 24 Jun 2025

Evaluating the immune response in a murine cancer model between irreversible electroporation and an advanced biphasic pulsed electric field technology

in Cancer Immunity and Immunotherapy

Ebtesam H. O. Nafie
Chiara Pastori
Robert E. Neal

Frontiers in Oncology

doi 10.3389/fonc.2025.1592610

206 views

Original Research

Accepted on 23 Jun 2025

Lactylation-related gene signatures identify glioma molecular subtypes with prognostic, immunological, and therapeutic implications

in Cancer Immunity and Immunotherapy

Yanliang Tang
Xiaoli Zhang
Xiaofei Tang
Ye Yuan
Wenwen Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1613423

Case Report

Accepted on 20 Jun 2025

Case Report: Personalized Peptide-Based Immunization in an Advanced-Stage Prostate Cancer Patient with Bone Metastasis

in Cancer Immunity and Immunotherapy

Nils Heinrich Thoennissen
Mari Carmen Martos-Contreras
Mehdi Manoochehri
Mauro Nogueira
Franziska Bremm
Jan Dörrie
Jan Christoph
Meik Kunz
Wolfgang Schönharting

Frontiers in Oncology

doi 10.3389/fonc.2025.1596315

Review

Accepted on 20 Jun 2025

Neurotransmitters: an emerging target for therapeutic resistance to

in Cancer Immunity and Immunotherapy

Jiyuan Yang
Hui Dai
Xinhui Lv
Yu Wu
Zhong Li
Xudong Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1622759

Original Research

Accepted on 20 Jun 2025

Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in non-small cell Lung Cancer patients undergoing anti-PD1 therapy

in Cancer Immunity and Immunotherapy

Kriti Jain
Anika Goel
Deepa Mehra
Deepak Kumar Rathore
Akshay Binayke
Shyam Aggarwal
Surajit Ganguly
Amit Awasthi
Evanka Madan
Nirmal Kumar Ganguly

Frontiers in Oncology

doi 10.3389/fonc.2025.1628379

Review

Published on 20 Jun 2025

Revolutions at the frontline of multiple myeloma treatment: lessons and challenges to finding a cure

in Cancer Immunity and Immunotherapy

Jeries Kort
Andrea Rivera
Sindhuja Senigarapu
James J. Driscoll

Frontiers in Oncology

doi 10.3389/fonc.2025.1578529

482 views

Mini Review

Accepted on 18 Jun 2025

Mapping the Immunological Landscape and Emerging Immunotherapeutic Strategies in Cervical Cancer: A Comprehensive Review

in Cancer Immunity and Immunotherapy

Xinyi Zhang
Wenyang Nie
Wenwen Shao
Qian Guo

Frontiers in Oncology

doi 10.3389/fonc.2025.1620501

118 views

Original Research

Published on 18 Jun 2025

IL-36-related genes predict prognosis of gastric cancer

in Cancer Immunity and Immunotherapy

Ying Zhang
Yanbo Liu
Xin Guan
Meng Qu
Dianxiu Wu
Ning Liu
Zhengkun Lin
Yuqi Liu
Han Wang
Lijuan Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1566993

359 views

Original Research

Published on 16 Jun 2025

Epithelial cells with high TOP2A expression promote cervical cancer progression by regulating the transcription factor FOXM1

in Cancer Immunity and Immunotherapy

Wei Sun
Lu Chen
Xiaoling Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1604960

278 views

Systematic Review

Published on 16 Jun 2025

Cancer immunotherapy nursing care from 2004 to 2023: a bibliometric analysis

in Cancer Immunity and Immunotherapy

Linjuan Li
Ruyu Ge
Tingting Wu
Hongyan Du
Xuanwei Zhang
Shiqi Tao
Linjun Zhong
Mingxia Li
Yan Fu
Yang Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1508029

344 views

Case Report

Published on 12 Jun 2025

Hyperprogression disease induced by Sintilimab combined with Oxaliplatin and S-1 after surgery: a case report and literature review

in Cancer Immunity and Immunotherapy

Yaoqi Li
You Wang
Rui Shen
Weijun Liu
Chenglou Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1494007

419 views

Original Research

Published on 12 Jun 2025

Prognostic analysis and association of the systemic immune-inflammatory index with immune checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Mengyao Cai
Jiangqian Sun
Jingyi Wu
Ya Liu
Yuanyi Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1596223

271 views

Original Research

Accepted on 11 Jun 2025

Association of visceral obesity indicators with prostate cancer: a cross-sectional study from Xinjiang

in Cancer Immunity and Immunotherapy

Zhiruo Cai
Xue Guan
Yunyun Xiao
Hengqing An
Ning Tao

Frontiers in Oncology

doi 10.3389/fonc.2025.1614743

154 views

Original Research

Published on 09 Jun 2025

Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status

in Cancer Immunity and Immunotherapy

Yongtao Li
Tangnuer Buerliesi
Wenting Xu
Lina Yi
Fulati Wuwalihan

Frontiers in Oncology

doi 10.3389/fonc.2025.1596156

698 views